EAU Guidelines on Renal Cell Carcinoma: The 2010 Update

Ljungberg, 2007, Renal cell carcinoma guideline, Eur Urol, 51, 1502, 10.1016/j.eururo.2007.03.035

Ferlay, 2010, Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer, 46, 765, 10.1016/j.ejca.2009.12.014

Levi, 2008, The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int, 101, 949, 10.1111/j.1464-410X.2008.07451.x

Hunt, 2005, Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies, Int J Cancer, 114, 101, 10.1002/ijc.20618

Pischon, 2006, Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC), Int J Cancer, 118, 728, 10.1002/ijc.21398

Weikert, 2008, Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition, Am J Epidemiol, 167, 438, 10.1093/aje/kwm321

Clague, 2009, Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis, Cancer Epidemiol Biomarkers Prev, 18, 801, 10.1158/1055-9965.EPI-08-0601

Sanz-Ortega, 2009, Hereditary renal cancer, Actas Urol Esp, 33, 127, 10.1016/S0210-4806(09)74111-7

Patard, 2003, Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma, Eur Urol, 44, 226, 10.1016/S0302-2838(03)00216-1

Motzer, 2002, Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma, J Clin Oncol, 20, 289, 10.1200/JCO.20.1.289

Israel, 2008, Pitfalls in renal mass evaluation and how to avoid them, Radiographics, 28, 1325, 10.1148/rg.285075744

Warren, 2005, The Bosniak classification of renal cystic masses, BJU Int, 95, 939, 10.1111/j.1464-410X.2005.05442.x

Putra, 2009, Improved assessment of renal lesions in pregnancy with magnetic resonance imaging, Urology, 74, 535, 10.1016/j.urology.2008.07.050

Park, 2009, Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma, BJU Int, 103, 615, 10.1111/j.1464-410X.2008.08150.x

Shannon, 2008, The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses, J Urol, 180, 1257, 10.1016/j.juro.2008.06.030

Remzi, 2009, Renal tumor biopsies for evaluation of small renal tumors: why, in whom and how?, Eur Urol, 55, 359, 10.1016/j.eururo.2008.09.053

2004, 7

Pignot, 2007, Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification, Urology, 69, 230, 10.1016/j.urology.2006.09.052

2009, 255

Capitanio, 2009, A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study, BJU Int, 103, 1496, 10.1111/j.1464-410X.2008.08259.x

Furge, 2007, Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling, Oncogene, 26, 1346, 10.1038/sj.onc.1210256

Sabatino, 2009, Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy, J Clin Oncol, 27, 2645, 10.1200/JCO.2008.19.1106

Zigeuner, 2010, External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology, Eur Urol, 57, 102, 10.1016/j.eururo.2008.11.033

Ramon, 2009, Renal angiomyolipoma: long-term results following selective arterial embolization, Eur Urol, 55, 1155, 10.1016/j.eururo.2008.04.025

Peycelon, 2009, Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4cm, J Urol, 181, 35, 10.1016/j.juro.2008.09.025

Luo, 2010, Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy, World J Urol, 28, 289, 10.1007/s00345-009-0487-9

Lane, 2009, Management of the adrenal gland during partial nephrectomy, J Urol, 181, 2430, 10.1016/j.juro.2009.02.027

Blom, 2009, Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881, Eur Urol, 55, 28, 10.1016/j.eururo.2008.09.052

Weight, 2010, Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses, J Urol, 183, 1317, 10.1016/j.juro.2009.12.030

Simmons, 2009, Laparoscopic radical versus partial nephrectomy for tumors >4cm: intermediate-term oncologic and functional outcomes, Urology, 73, 1077, 10.1016/j.urology.2008.11.059

Pasticier, 2006, Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period, Eur Urol, 49, 485, 10.1016/j.eururo.2005.12.049

Bensalah, 2010, Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery, Eur Urol, 57, 466, 10.1016/j.eururo.2009.03.048

Burgess, 2007, Randomized trial of laparoscopic v open nephrectomy, J Endourol, 21, 610, 10.1089/end.2006.0277

Godoy, 2009, Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate, J Urol, 181, 2438, 10.1016/j.juro.2009.02.026

May, 2009, Preoperative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma, Br J Radiol, 82, 724, 10.1259/bjr/17514226

Forauer, 2007, Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma, Acta Oncol, 46, 1012, 10.1080/02841860701280725

Rais-Bahrami, 2009, Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention, BJU Int, 103, 1355, 10.1111/j.1464-410X.2008.08242.x

Kunkle, 2008, Cryoablation or radiofrequency ablation of the small renal mass: a metaanalysis, Cancer, 113, 2671, 10.1002/cncr.23896

Flanigan, 2004, Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis, J Urol, 171, 1071, 10.1097/01.ju.0000110610.61545.ae

van der Poel, 1999, Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis, Eur Urol, 35, 197, 10.1159/000019849

Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev 2005:CD001425.

Patard, 2006, Understanding the importance of smart drugs in renal cell carcinoma, Eur Urol, 49, 633, 10.1016/j.eururo.2006.01.016

Escudier, 2007, Sorafenib in advanced clear-cell renal-cell carcinoma, N Engl J Med, 356, 125, 10.1056/NEJMoa060655

Motzer, 2009, Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma, J Clin Oncol, 27, 3584, 10.1200/JCO.2008.20.1293

Sternberg, 2010, Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial, J Clin Oncol, 28, 1061, 10.1200/JCO.2009.23.9764

Escudier, 2007, Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial, Lancet, 370, 2103, 10.1016/S0140-6736(07)61904-7

Hudes, 2007, Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma, N Engl J Med, 356, 2271, 10.1056/NEJMoa066838

Motzer, 2008, Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial, Lancet, 372, 449, 10.1016/S0140-6736(08)61039-9

Lam, 2005, Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy, J Urol, 173, 1853, 10.1097/01.ju.0000165693.68449.c3

Cindolo, 2005, Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study, Cancer, 104, 1362, 10.1002/cncr.21331